v3.26.1
SUBSEQUENT EVENTS (Details Narrative) - USD ($)
 1 Months Ended 3 Months Ended 12 Months Ended
Sep. 15, 2026
Jun. 15, 2026
May 12, 2026
May 06, 2026
Apr. 27, 2026
Apr. 15, 2026
Mar. 20, 2026
Mar. 15, 2026
Jan. 28, 2026
Sep. 02, 2025
Jul. 17, 2025
Apr. 17, 2025
Mar. 15, 2025
May 08, 2026
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Apr. 01, 2026
Jan. 18, 2026
Jan. 17, 2026
Sep. 22, 2025
Sep. 21, 2025
Oct. 16, 2024
Aug. 16, 2024
Shares authorized             25,020,000,000               10,010,000,000                  
Preferred stock, shares authorized             20,000,000               10,000,000                  
Preferred stock, par value             $ 0.0001                                  
Common stock, par value                             $ 0.0001                  
Reverse stock split                   effect a reverse stock split of our issued and outstanding Common Stock any time before July 31, 2026, at a ratio ranging from one-for-ten (1:10) to one-for-five hundred (1:500) with the exact ratio within such range 1-for-1.99 reverse stock split, such that every 1.99 shares of the Company’s Class A Common Stock will be combined into one issued and outstanding share of the Company’s Class A Common Stock, with no change in the $0.0001 par value per share (the “Second Reverse Stock Split”) and together with the First Reverse Stock Split, (the “Reverse Stock Splits”) 1-for-10 reverse stock split, such that every 10 shares of the Company’s Class A Common Stock will be combined into one issued and outstanding share of Common Stock                        
Repayment of debt                             $ 300,000   $ 300,000              
Conversions of Series A Preferred Stock into common stock, shares                               217,302                
Conversions of Series A Preferred Stock into common stock                                            
Two Unsecured Promissory Notes [Member]                                                
Principal amount                 $ 280,000       $ 47,500                      
Original issue discount                 $ 15,000       $ 5,000                      
Increase in principal amount             $ 32,000                                  
Maturity date             May 31, 2026   Mar. 26, 2026       May 15, 2026                      
Legal fees             $ 4,000 $ 2,500 $ 15,000                              
Two Unsecured Promissory Notes [Member] | Forecast [Member]                                                
Legal fees $ 14,000                                              
Two Additional Unsecured Promissory Notes [Member] | Forecast [Member]                                                
Repayment of debt   $ 50,000                                            
ClearThink Capital Partners LLC [Member]                                                
Interest rate                                               12.00%
Subsequent Event [Member]                                                
Shares authorized                                   25,020,000,000            
Preferred stock, shares authorized                                   20,000,000            
Subsequent Event [Member] | One Holder [Member]                                                
Principal amount     $ 5,307,097                                          
Subsequent Event [Member] | Two Holder [Member]                                                
Principal amount     2,467,988                                          
Subsequent Event [Member] | Holders [Member]                                                
Principal amount     $ 7,775,085                                          
Interest rate     18.00%                                          
Subsequent Event [Member] | Two Unsecured Promissory Notes [Member]                                                
Principal amount       $ 240,000                                        
Original issue discount       40,000                                        
Increase in principal amount       $ 308,000                                        
Maturity date       May 31, 2026 to September 15, 2026.                                        
Extension amount       $ 336,000                                        
Note due amount       $ 150,000                                        
Debt instrument description       In connection with the extension, the Company also agreed that 50% of the gross proceeds of any equity, debt or equity-linked financing completed prior to final payment will be applied to repay these notes (and, thereafter, the March 15, 2025 notes and the May 6, 2026 notes) in a specified order of priority.                                        
Maturity date       Dec. 15, 2026                                        
Interest rate       18.00%                                        
Subsequent Event [Member] | Unsecured Promissory Notes [Member]                                                
Principal amount       $ 240,000                                        
Original issue discount       $ 40,000                                        
Maturity date       Dec. 15, 2026                                        
Legal fees       $ 14,000                                        
Interest rate       18.00%                                        
Subsequent Event [Member] | Two Additional Unsecured Promissory Notes [Member]                                                
Maturity date       May 15, 2026 to June 15, 2026.                                        
Subsequent Event [Member] | Two Additional Unsecured Promissory Notes [Member] | Minimum [Member]                                                
Principal amount       $ 47,500                                        
Subsequent Event [Member] | Two Additional Unsecured Promissory Notes [Member] | Maximum [Member]                                                
Principal amount       $ 50,000                                        
Subsequent Event [Member] | Rennova Health Inc [Member]                                                
Principal amount           $ 202,365                                    
Net cash proceeds           126,900                                    
Original issue discount           75,465                                    
Repayment of debt           $ 8,464                                    
Subsequent Event [Member] | ClearThink Capital Partners LLC [Member] | Convertible Unsecured Promissory Notes [Member] | Securities Purchase Agreement [Member]                                                
Principal amount         $ 12,000                                      
Increase in principal amount         $ 127,000                                      
Interest rate         18.00%                                      
Rennova Health Inc [Member]                                                
Voting equity interest acquired, percentage             97.59%                                  
Common Class A [Member]                                                
Common stock, shares authorized             25,000,000,000               10,000,000,000   10,000,000,000   10,000,000,000 2,500,000,000        
Common stock, par value             $ 0.0001               $ 0.0001   $ 0.0001              
Common Class A [Member] | Subsequent Event [Member]                                                
Common stock, shares authorized                                   25,000,000,000            
Number of shares issued                           379,000,000                    
Conversions of Series A Preferred Stock into common stock, shares                           37.9                    
Common Class A [Member] | Subsequent Event [Member] | ClearThink Capital Partners LLC [Member] | Convertible Unsecured Promissory Notes [Member]                                                
Number of shares issued         150,000,000                                      
Preferred Class A [Member] | Subsequent Event [Member]                                                
Conversions of Series A Preferred Stock into common stock                           $ 37,900                    
Series A Preferred Stock [Member]                                                
Preferred stock, shares authorized                             50,000   50,000       50,000 35,000 35,000  
Preferred stock, par value                             $ 0.0001   $ 0.0001       $ 0.0001      
Number of shares issued                             0 0                
Series A Preferred Stock [Member] | Subsequent Event [Member] | One Holder [Member]                                                
Stock Issued During Period, Shares, Other     5,307                                          
Stock Issued During Period, Value, Other     $ 5,307,097                                          
Series A Preferred Stock [Member] | Subsequent Event [Member] | Two Holder [Member]                                                
Stock Issued During Period, Shares, Other     2,468                                          
Stock Issued During Period, Value, Other     $ 2,467,988